
LETONIK 5mg Tablet
Marketer
Amagen India Life Sciences
Salt Composition
Letrozole (5mg)
Overview LETONIK 5mg Tablet
Post-menopausal women with breast cancer may find relief with LETONIK 5mg Tablets. This medication can be used independently or alongside other therapies like surgery or radiation. In advanced cases, it helps prevent cancer spread. LETONIK 5mg Tablets may be taken with or without food, always adhering to your doctor's prescribed dosage and duration for optimal results. Dosage varies depending on the specific treatment plan. Your physician will determine the appropriate amount to alleviate your symptoms. Continue taking this medication for the prescribed period. Common side effects include hot flushes, tiredness, excessive sweating, and elevated cholesterol. Report any concerning side effects to your doctor; management strategies may be available. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or a history of osteoporosis. Complete disclosure of all other medications is crucial, as interactions may impact LETONIK's efficacy. Additionally, disclose any pregnancy or breastfeeding. Your doctor may order blood tests to assess vitamin D levels and bone density before and throughout treatment.
Primary Ingredients of LETONIK 5mg Tablet
No text provided to rephrase.
Uses of LETONIK 5mg Tablet
Managing breast cancer
Major Benefits of LETONIK 5mg Tablet:
Consume LETONIK 5mg Tablet precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. This medication can be administered with or without food, though consistent timing is recommended for optimal results.
Common Side effects of LETONIK 5mg Tablet:
- Dizziness
- Fatigue
- Weakness
- Bone pain
- Back pain
- Night sweats
- Joint pain
- Nausea
- Osteoporosis
- Joint inflammation
- Weight gain
- Hot flushes
- Edema (swelling)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Diaphoresis
- Bone fracture
- Hypercholesterolemia (high cholesterol)
- Cough
- Shortness of breath
How to use LETONIK 5mg Tablet:
Consume LETONIK 5mg Tablet precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistency in timing is recommended.
How LETONIK 5mg Tablet works:
Aromatase inhibitor LETONIK 5mg tablets reduce the body's estrogen production, a crucial female hormone. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between LETONIK 5mg Tablet and alcohol consumption.
PregnancyUNSAFE
The use of LETONIK 5mg Tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in animal models and pregnant humans has revealed substantial adverse effects on fetal development.
Breast feedingUNSAFE
Administration of LETONIK 5mg tablets is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Taking a 5mg LETONIK Tablet might reduce alertness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, the 5mg LETONIK tablet is considered safe, and no dosage modification is typically necessary. Nevertheless, data regarding its use in patients with end-stage renal disease is scarce. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use LETONIK 5mg Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take LETONIK 5mg Tablet :
Should you forget a LETONIK 5mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About LETONIK 5mg Tablet
| Label | Value |
|---|---|
| Pharmaceutical Category | Benzophenone-related compound |
| Potential for Dependence | None. |
| Medication Classification | Cancer therapeutics |
